These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Fixed drug eruption due to rifampin. John SS Lepr Rev; 1998 Dec; 69(4):397-9. PubMed ID: 9927813 [TBL] [Abstract][Full Text] [Related]
7. Rifampicin as treatment for pruritus in malignant cholestasis: an example of an improper indication for anti-infective drugs. Castagnola E; Viscoli C Support Care Cancer; 1999 May; 7(3):160. PubMed ID: 10335936 [No Abstract] [Full Text] [Related]
8. Rifampin (INN Rifampicin). Howard P; Twycross R; Grove G; Charlesworth S; Mihalyo M; Wilcock A J Pain Symptom Manage; 2015 Dec; 50(6):891-5. PubMed ID: 26432572 [TBL] [Abstract][Full Text] [Related]
9. New drugs 99, Part III. Hussar DA Nursing; 1999 Jun; 29(6):43-7; quiz 48. PubMed ID: 10418507 [No Abstract] [Full Text] [Related]
10. Rifampin-containing regimens for community-associated skin infection: a hazard without known benefit. Miller LG; Boucher H Am J Emerg Med; 2009 Sep; 27(7):893-4. PubMed ID: 19683124 [No Abstract] [Full Text] [Related]
11. Multidrug resistant Mycobacterium leprae from patients with leprosy. Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358 [TBL] [Abstract][Full Text] [Related]
12. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks. Ji B Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368 [No Abstract] [Full Text] [Related]
13. First assessment of the Malta Leprosy Eradication Project. Leiker DL Lepr Rev; 1986; 57 Suppl 3():42-6. PubMed ID: 3573959 [No Abstract] [Full Text] [Related]
14. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme. Chum HJ Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963 [No Abstract] [Full Text] [Related]
15. Interaction between ciprofloxacin and rifampin. Temple ME; Nahata MC Ann Pharmacother; 1999; 33(7-8):868-70. PubMed ID: 10466918 [TBL] [Abstract][Full Text] [Related]